Alogliptin
SYR-322/CCT-001
Approved small_molecule completed
Quick answer
Alogliptin for Diabetes Mellitus, Type 2 is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 6 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Diabetes Mellitus, Type 2
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed